Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment.
作者信息
Grosser Tilo, Naji Ali, FitzGerald Garret A
机构信息
From the Institute for Translational Medicine and Therapeutics (T.G., G.A.F.) and Department of Surgery (A.N.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.
出版信息
Circ Res. 2018 Feb 16;122(4):537-539. doi: 10.1161/CIRCRESAHA.118.312616.
Abstract
摘要
相似文献
1
Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment.
Circ Res. 2018 Feb 16;122(4):537-539. doi: 10.1161/CIRCRESAHA.118.312616.
2
Letter by Mitchell et al Regarding Article, "Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment".
Circ Res. 2018 May 11;122(10):e84-e85. doi: 10.1161/CIRCRESAHA.118.312976.
3
Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine.
Gastroenterology. 1981 Sep;81(3):444-9.
4
Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Circulation. 1980 Dec;62(6 Pt 2):V19-25.
5
Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine.
Clin Sci (Lond). 1987 Sep;73(3):277-83. doi: 10.1042/cs0730277.
6
7
Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.
Prostaglandins. 1977;14(6):1043-53. doi: 10.1016/0090-6980(77)90284-2.
8
Urinary prostacyclin and thromboxane A2 metabolites in preterm and full-term infants in relation to plasma renin activity and blood pressure.
Biol Neonate. 1982;42(3-4):179-84. doi: 10.1159/000241594.
9
A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
J Clin Invest. 1981 Oct;68(4):981-7. doi: 10.1172/jci110352.
10
Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.
Br Med J (Clin Res Ed). 1981 Nov 21;283(6303):1351-2. doi: 10.1136/bmj.283.6303.1351.
引用本文的文献
1
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents.
Lancet Infect Dis. 2023 Jan;23(1):e22-e33. doi: 10.1016/S1473-3099(22)00433-9. Epub 2022 Aug 26.
2
Prostanoid Metabolites as Biomarkers in Human Disease.
Metabolites. 2022 Aug 4;12(8):721. doi: 10.3390/metabo12080721.
3
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.
Adv Biol Regul. 2021 Aug;81:100818. doi: 10.1016/j.jbior.2021.100818. Epub 2021 Jul 15.
4
Longitudinal profiles of plasma eicosanoids during pregnancy and size for gestational age at delivery: A nested case-control study.
PLoS Med. 2020 Aug 14;17(8):e1003271. doi: 10.1371/journal.pmed.1003271. eCollection 2020 Aug.
5
Identification of a homozygous recessive variant in resulting in a congenital aspirin-like defect in platelet function.
Haematologica. 2021 May 1;106(5):1423-1432. doi: 10.3324/haematol.2019.235895.
6
Measurement of Thromboxane Biosynthesis in Health and Disease.
Front Pharmacol. 2019 Oct 30;10:1244. doi: 10.3389/fphar.2019.01244. eCollection 2019.
7
Isoform-Specific Compensation of Cyclooxygenase (Ptgs) Genes during Implantation and Late-Stage Pregnancy.
Sci Rep. 2018 Aug 14;8(1):12097. doi: 10.1038/s41598-018-30636-x.
8
Letter by Mitchell et al Regarding Article, "Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment".
Circ Res. 2018 May 11;122(10):e84-e85. doi: 10.1161/CIRCRESAHA.118.312976.
9
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
Intern Emerg Med. 2018 Aug;13(5):651-660. doi: 10.1007/s11739-018-1835-9. Epub 2018 Mar 26.
本文引用的文献
1
Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A Proves Renal Origins of Urinary PGI-M and TX-M.
Circ Res. 2018 Feb 16;122(4):555-559. doi: 10.1161/CIRCRESAHA.117.312144. Epub 2018 Jan 3.
2
Vascular COX-2 modulates blood pressure and thrombosis in mice.
Sci Transl Med. 2012 May 2;4(132):132ra54. doi: 10.1126/scitranslmed.3003787.
3
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.
J Clin Invest. 2006 Jan;116(1):4-15. doi: 10.1172/JCI27291.
4
Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers.
Circulation. 2005 Aug 16;112(7):1024-9. doi: 10.1161/CIRCULATIONAHA.105.542696. Epub 2005 Aug 8.
5
Natural history, risk factors, and impact of subclinical rejection in kidney transplantation.
Transplantation. 2004 Jul 27;78(2):242-9. doi: 10.1097/01.tp.0000128167.60172.cc.
6
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
Circulation. 1983 Jun;67(6):1174-7. doi: 10.1161/01.cir.67.6.1174.
7
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
J Clin Invest. 1983 Mar;71(3):676-88. doi: 10.1172/jci110814.
8
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
J Clin Invest. 1983 Mar;71(3):762-8. doi: 10.1172/jci110824.
9
Estimated rate of thromboxane secretion into the circulation of normal humans.
J Clin Invest. 1986 Feb;77(2):590-4. doi: 10.1172/JCI112341.
10
Paired analysis of urinary thromboxane B2 metabolites in humans.
Thromb Res. 1987 Sep 15;47(6):647-56. doi: 10.1016/0049-3848(87)90103-4.
Zotero 插件